KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Account Payables (2016 - 2025)

Rigel Pharmaceuticals has reported Change in Account Payables over the past 16 years, most recently at $3.3 million for Q4 2025.

  • Quarterly results put Change in Account Payables at $3.3 million for Q4 2025, up 802.73% from a year ago — trailing twelve months through Dec 2025 was $3.9 million (up 201.29% YoY), and the annual figure for FY2025 was $3.9 million, up 201.29%.
  • Change in Account Payables for Q4 2025 was $3.3 million at Rigel Pharmaceuticals, up from -$3.4 million in the prior quarter.
  • Over the last five years, Change in Account Payables for RIGL hit a ceiling of $4.8 million in Q4 2022 and a floor of -$3.4 million in Q3 2025.
  • Median Change in Account Payables over the past 5 years was $600500.0 (2022), compared with a mean of $175600.0.
  • Biggest five-year swings in Change in Account Payables: tumbled 383.68% in 2021 and later surged 802.73% in 2025.
  • Rigel Pharmaceuticals' Change in Account Payables stood at $697000.0 in 2021, then surged by 586.8% to $4.8 million in 2022, then tumbled by 117.9% to -$857000.0 in 2023, then skyrocketed by 44.46% to -$476000.0 in 2024, then surged by 802.73% to $3.3 million in 2025.
  • The last three reported values for Change in Account Payables were $3.3 million (Q4 2025), -$3.4 million (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.